Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang, Hussin Muhammad
{"title":"A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.","authors":"Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang, Hussin Muhammad","doi":"10.3390/cimb46100682","DOIUrl":null,"url":null,"abstract":"<p><p>Liver diseases cause millions of deaths globally. Current treatments are often limited in effectiveness and availability, driving the search for alternatives. Herbal preparations offer potential hepatoprotective properties. Disrupted gut microbiota is linked to liver disorders. This scoping review aims to explore the effects of herbal preparations on hepatoprotective mechanisms, particularly in the context of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatic steatosis, with a focus on gut microbiota modulation. A systematic search was performed using predetermined keywords in four electronic databases (PubMed, Scopus, EMBASE, and Web of Science). A total of 55 studies were included for descriptive analysis, covering study characteristics such as disease model, dietary model, animal model, intervention details, comparators, and study outcomes. The findings of this review suggest that the hepatoprotective effects of herbal preparations are closely related to their interactions with the gut microbiota. The hepatoprotective mechanisms of herbal preparations are shown through their effects on the gut microbiota composition, intestinal barrier, and microbial metabolites, which resulted in decreased serum levels of liver enzymes and lipids, improved liver pathology, inhibition of hepatic fatty acid accumulation, suppression of inflammation and oxidative stress, reduced insulin resistance, and altered bile acid metabolism.</p>","PeriodicalId":10839,"journal":{"name":"Current Issues in Molecular Biology","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506797/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Issues in Molecular Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3390/cimb46100682","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Liver diseases cause millions of deaths globally. Current treatments are often limited in effectiveness and availability, driving the search for alternatives. Herbal preparations offer potential hepatoprotective properties. Disrupted gut microbiota is linked to liver disorders. This scoping review aims to explore the effects of herbal preparations on hepatoprotective mechanisms, particularly in the context of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatic steatosis, with a focus on gut microbiota modulation. A systematic search was performed using predetermined keywords in four electronic databases (PubMed, Scopus, EMBASE, and Web of Science). A total of 55 studies were included for descriptive analysis, covering study characteristics such as disease model, dietary model, animal model, intervention details, comparators, and study outcomes. The findings of this review suggest that the hepatoprotective effects of herbal preparations are closely related to their interactions with the gut microbiota. The hepatoprotective mechanisms of herbal preparations are shown through their effects on the gut microbiota composition, intestinal barrier, and microbial metabolites, which resulted in decreased serum levels of liver enzymes and lipids, improved liver pathology, inhibition of hepatic fatty acid accumulation, suppression of inflammation and oxidative stress, reduced insulin resistance, and altered bile acid metabolism.
肝脏疾病导致全球数百万人死亡。目前的治疗方法往往在有效性和可用性方面受到限制,因此人们开始寻找替代疗法。草药制剂具有潜在的保肝特性。肠道微生物群紊乱与肝脏疾病有关。本范围综述旨在探讨草药制剂对肝脏保护机制的影响,尤其是在非酒精性脂肪肝(NAFLD)、非酒精性脂肪性肝炎(NASH)和肝脂肪变性的背景下,重点关注肠道微生物群的调节。我们使用预先确定的关键词在四个电子数据库(PubMed、Scopus、EMBASE 和 Web of Science)中进行了系统检索。共纳入 55 项研究进行描述性分析,涵盖疾病模型、饮食模型、动物模型、干预细节、比较对象和研究结果等研究特征。综述结果表明,中草药制剂的保肝作用与其与肠道微生物群的相互作用密切相关。中草药制剂的保肝机制是通过其对肠道微生物群组成、肠道屏障和微生物代谢产物的影响,从而降低血清中肝脏酶和脂质的水平,改善肝脏病理,抑制肝脏脂肪酸积累,抑制炎症和氧化应激,降低胰岛素抵抗,改变胆汁酸代谢。
期刊介绍:
Current Issues in Molecular Biology (CIMB) is a peer-reviewed journal publishing review articles and minireviews in all areas of molecular biology and microbiology. Submitted articles are subject to an Article Processing Charge (APC) and are open access immediately upon publication. All manuscripts undergo a peer-review process.